Hypopituitarism epidemiology and demographics: Difference between revisions
Jump to navigation
Jump to search
m Bot: Removing from Primary care |
|||
(3 intermediate revisions by 3 users not shown) | |||
Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
In a longitudinal survey (1992-1999), the incidence of hypopituitarism was estimated to be 4.2 cases per 100,000. A study comprising two cross-sectional surveys showed the prevalence of hypopituitarism to be 29-45.5 per 100.000 individual. | In a longitudinal survey (1992-1999), the incidence of [[hypopituitarism]] was estimated to be 4.2 cases per 100,000. A study comprising two cross-sectional surveys showed the prevalence of [[hypopituitarism]] to be 29 - 45.5 per 100.000 individual. | ||
==Epidemiology and Demographics== | ==Epidemiology and Demographics== | ||
There is one study performed in northern Spain, regarding hypopituitarism epidemiology combining two cross-sectional surveys (from 1992 and 1999).<ref name="pmid11895214">{{cite journal |vauthors=Regal M, Páramo C, Sierra SM, Garcia-Mayor RV |title=Prevalence and incidence of hypopituitarism in an adult Caucasian population in northwestern Spain |journal=Clin. Endocrinol. (Oxf) |volume=55 |issue=6 |pages=735–40 |year=2001 |pmid=11895214 |doi= |url=}}</ref> | * There is one study performed in northern Spain, regarding [[hypopituitarism]] [[epidemiology]] combining two cross-sectional surveys (from 1992 and 1999).<ref name="pmid11895214">{{cite journal |vauthors=Regal M, Páramo C, Sierra SM, Garcia-Mayor RV |title=Prevalence and incidence of hypopituitarism in an adult Caucasian population in northwestern Spain |journal=Clin. Endocrinol. (Oxf) |volume=55 |issue=6 |pages=735–40 |year=2001 |pmid=11895214 |doi= |url=}}</ref> | ||
===Incidence=== | ===Incidence=== | ||
*In a longitudinal survey (1992-1999), the incidence of hypopituitarism was estimated to be 4.2 cases per 100,000.<ref name="pmid11895214">{{cite journal |vauthors=Regal M, Páramo C, Sierra SM, Garcia-Mayor RV |title=Prevalence and incidence of hypopituitarism in an adult Caucasian population in northwestern Spain |journal=Clin. Endocrinol. (Oxf) |volume=55 |issue=6 |pages=735–40 |year=2001 |pmid=11895214 |doi= |url=}}</ref> | *In a longitudinal survey (1992-1999), the incidence of [[hypopituitarism]] was estimated to be 4.2 cases per 100,000.<ref name="pmid11895214">{{cite journal |vauthors=Regal M, Páramo C, Sierra SM, Garcia-Mayor RV |title=Prevalence and incidence of hypopituitarism in an adult Caucasian population in northwestern Spain |journal=Clin. Endocrinol. (Oxf) |volume=55 |issue=6 |pages=735–40 |year=2001 |pmid=11895214 |doi= |url=}}</ref> | ||
*A study was done to find out etiological distribution among 773 adults with hypopituitarism that showed:<ref name="pmid24366641">{{cite journal |vauthors=Tanriverdi F, Dokmetas HS, Kebapcı N, Kilicli F, Atmaca H, Yarman S, Ertorer ME, Erturk E, Bayram F, Tugrul A, Culha C, Cakir M, Mert M, Aydin H, Taskale M, Ersoz N, Canturk Z, Anaforoglu I, Ozkaya M, Oruk G, Hekimsoy Z, Kelestimur F, Erbas T |title=Etiology of hypopituitarism in tertiary care institutions in Turkish population: analysis of 773 patients from Pituitary Study Group database |journal=Endocrine |volume=47 |issue=1 |pages=198–205 |year=2014 |pmid=24366641 |doi=10.1007/s12020-013-0127-4 |url=}}</ref> | *A study was done to find out etiological distribution among 773 adults with [[hypopituitarism]] that showed:<ref name="pmid24366641">{{cite journal |vauthors=Tanriverdi F, Dokmetas HS, Kebapcı N, Kilicli F, Atmaca H, Yarman S, Ertorer ME, Erturk E, Bayram F, Tugrul A, Culha C, Cakir M, Mert M, Aydin H, Taskale M, Ersoz N, Canturk Z, Anaforoglu I, Ozkaya M, Oruk G, Hekimsoy Z, Kelestimur F, Erbas T |title=Etiology of hypopituitarism in tertiary care institutions in Turkish population: analysis of 773 patients from Pituitary Study Group database |journal=Endocrine |volume=47 |issue=1 |pages=198–205 |year=2014 |pmid=24366641 |doi=10.1007/s12020-013-0127-4 |url=}}</ref> | ||
**Non-tumoral etiology (50%) | **Non-tumoral [[etiology]] (50%) | ||
**[[Pituitary tumors]] (43.6 %) | **[[Pituitary tumors]] (43.6 %) | ||
**Extra-pituitary tumors (7.2%) | **Extra-[[pituitary]] tumors (7.2%) | ||
===Prevalence=== | ===Prevalence=== | ||
* There is a limited information regarding the prevalence of hypopituitarism. | * There is a limited information regarding the prevalence of [[hypopituitarism]]. | ||
* The prevalence of hypopituitarism was found to be 29-45.5 per 100,000 individual in the two cross-sectional studies.<ref name="pmid11895214">{{cite journal |vauthors=Regal M, Páramo C, Sierra SM, Garcia-Mayor RV |title=Prevalence and incidence of hypopituitarism in an adult Caucasian population in northwestern Spain |journal=Clin. Endocrinol. (Oxf) |volume=55 |issue=6 |pages=735–40 |year=2001 |pmid=11895214 |doi= |url=}}</ref> | * The prevalence of [[hypopituitarism]] was found to be 29 - 45.5 per 100,000 individual in the two cross-sectional studies.<ref name="pmid11895214">{{cite journal |vauthors=Regal M, Páramo C, Sierra SM, Garcia-Mayor RV |title=Prevalence and incidence of hypopituitarism in an adult Caucasian population in northwestern Spain |journal=Clin. Endocrinol. (Oxf) |volume=55 |issue=6 |pages=735–40 |year=2001 |pmid=11895214 |doi= |url=}}</ref> | ||
===Gender=== | ===Gender=== | ||
* Men and women are affected equally by hypopituitarism. | * Men and women are affected equally by [[hypopituitarism]]. | ||
===Age=== | ===Age=== | ||
*Hypopituitarism occurs at any age. | *[[Hypopituitarism]] occurs at any age. | ||
===Race=== | ===Race=== | ||
*There is no racial predilection for hypopituitarism. | *There is no [[racial]] predilection for [[hypopituitarism]]. | ||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
| |||
{{WH}} | {{WH}} | ||
{{WS}} | {{WS}} | ||
[[Category:Medicine]] | |||
[[Category:Endocrinology]] | |||
[[Category:Up-To-Date]] |
Latest revision as of 22:19, 29 July 2020
Hypopituitarism Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Hypopituitarism epidemiology and demographics On the Web |
American Roentgen Ray Society Images of Hypopituitarism epidemiology and demographics |
Risk calculators and risk factors for Hypopituitarism epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ahmed Elsaiey, MBBCH [2], Iqra Qamar M.D.[3]
Overview
In a longitudinal survey (1992-1999), the incidence of hypopituitarism was estimated to be 4.2 cases per 100,000. A study comprising two cross-sectional surveys showed the prevalence of hypopituitarism to be 29 - 45.5 per 100.000 individual.
Epidemiology and Demographics
- There is one study performed in northern Spain, regarding hypopituitarism epidemiology combining two cross-sectional surveys (from 1992 and 1999).[1]
Incidence
- In a longitudinal survey (1992-1999), the incidence of hypopituitarism was estimated to be 4.2 cases per 100,000.[1]
- A study was done to find out etiological distribution among 773 adults with hypopituitarism that showed:[2]
- Non-tumoral etiology (50%)
- Pituitary tumors (43.6 %)
- Extra-pituitary tumors (7.2%)
Prevalence
- There is a limited information regarding the prevalence of hypopituitarism.
- The prevalence of hypopituitarism was found to be 29 - 45.5 per 100,000 individual in the two cross-sectional studies.[1]
Gender
- Men and women are affected equally by hypopituitarism.
Age
- Hypopituitarism occurs at any age.
Race
- There is no racial predilection for hypopituitarism.
References
- ↑ 1.0 1.1 1.2 Regal M, Páramo C, Sierra SM, Garcia-Mayor RV (2001). "Prevalence and incidence of hypopituitarism in an adult Caucasian population in northwestern Spain". Clin. Endocrinol. (Oxf). 55 (6): 735–40. PMID 11895214.
- ↑ Tanriverdi F, Dokmetas HS, Kebapcı N, Kilicli F, Atmaca H, Yarman S, Ertorer ME, Erturk E, Bayram F, Tugrul A, Culha C, Cakir M, Mert M, Aydin H, Taskale M, Ersoz N, Canturk Z, Anaforoglu I, Ozkaya M, Oruk G, Hekimsoy Z, Kelestimur F, Erbas T (2014). "Etiology of hypopituitarism in tertiary care institutions in Turkish population: analysis of 773 patients from Pituitary Study Group database". Endocrine. 47 (1): 198–205. doi:10.1007/s12020-013-0127-4. PMID 24366641.